• White LinkedIn Icon
  • White Twitter Icon

Borman & Company, LLC
Innovation Advisors

 phone: +1 (508) 294-1402


© 2019 Borman and Company

Guiding the Value 

Chain of Innovation

About Borman & Company

With more than 75 years of combined experience in intellectual property management, Borman & Company supports research-intensive clients, including medical centers and universities, manage their value chain of innovation. We work with world-class institutions to forge successful private sector research and licensing relationships, harness the data and financial infrastructure required for Bayh-Dole compliance and advance effective technology transfer through every step along the path to commercialization.

Areas of Expertise

Intellectual Property Evaluation

  • IP portfolio management

  • Competitive technical analysis

  • Market opportunity identification

Licensing and Patents

  • Patent docketing & analysis

  • Licensing structure, negotiation

  • Royalty investigation/reconstruction

Tech Transfer

  • Connect private & public partners

  • Value optimization

  • Business model optimization

Open Innovation

  • Innovation strategy advisory

  • Change management

  • Innovation culture development

Invention/Technology Sourcing

  • Research partner identification

  • Partner relationship structure

  • Technical innovation sourcing

Bayh-Dole Compliance

  • iEdison reporting

  • Disclosure research

  • Data forensics and remediation

Visit Tech Transfer Compliance Central
Helping our clients be strong stewards of innovation.

“Borman & Company combines a high level vision of the institution and its business objectives with superior tactical execution skills to keep the project on track to meet the timetable and milestones.”

What's New?

Although it’s been more than a year since new Bayh-Dole reporting requirements were announced, we continue to see our clients challenged with the best process and tactics to implement the changes going forward. And with the recent news that NIST will take over the iEdison system from NIH and further regulatory updates to...

The original motivation for the Bayh-Dole Act was to encourage the commercialization of academic innovation so that new technologies could be available for the benefit of all. Yet today, I feel compelled to call attention to a compliance landscape that is significantly different than that of the past four decades—one tha...

New Bayh-Dole reporting requirements may put SBIR/STTR intellectual property at risk.

Higher education is under fire. With costs spiraling upward, student applications down, a new excise tax levied on endowments, universities large and small are grappling with their fiscal foundation. Yet, if university presidents take the time to glance inward, they may find a strong contributor to revenue within their h...

For institutions that depend on federal funding to support their research, lack of compliance with Bayh-Dole mandates can jeopardize ownership of inventions and associated patent rights. For attorneys who serve these clients in protection of intellectual property this should be a concern.  Many medical research centers,...

Why is research dying in the private sector? Is there any “R” left in R&D? Although we've certainly seen a decline in recent years, those researchers and scientists left in the private sector appear to have battened down the hatches.

With increased scrutiny by Congress about enforcement of the Bayh-Dole act, institutions with federally funded research programs are under the gun to structure an effective and comprehensive program for compliance and reporting.

Please reload